Intermediate osteopetrosis

Intermediate osteopetrosis (also known as autosomal recessive osteopetrosis, intermediate form, or IRO) is a rare inherited skeletal disorder characterized by abnormally dense bones due to defective osteoclast-mediated bone resorption. It is classified as an intermediate form between the severe infantile (malignant) autosomal recessive osteopetrosis and the milder autosomal dominant osteopetrosis (Albers-Schönberg disease), sharing features of both but with a generally less life-threatening course than the infantile form. The disease primarily affects the skeletal system, leading to diffuse osteosclerosis (increased bone density) visible on radiographs. Key clinical features include an increased susceptibility to fractures despite the dense bones (because the bone is structurally abnormal and brittle), short stature, mild to moderate anemia, and in some cases cranial nerve compression leading to visual or hearing impairment. Dental abnormalities, including delayed tooth eruption and dental abscesses, are also commonly reported. Some patients may develop hepatosplenomegaly due to extramedullary hematopoiesis, though this is typically less severe than in the infantile form. Mutations in the CLCN7 gene (encoding a chloride channel important for osteoclast function) and, less commonly, the PLEKHM1 gene have been identified as causes of intermediate osteopetrosis. Treatment is largely supportive and symptom-directed. Management may include orthopedic care for fractures, dental surveillance, monitoring and treatment of anemia, and ophthalmologic and audiologic evaluations for cranial nerve complications. Unlike the severe infantile form, hematopoietic stem cell transplantation is generally not required, although it may be considered in cases with significant hematologic compromise. Interferon gamma-1b has been used in some cases to improve immune function and bone resorption. Prognosis is variable but generally more favorable than the malignant infantile form, with many patients surviving into adulthood.

Common questions about Intermediate osteopetrosis